[5]
Shabnashmi PS, Naga KS, Vithya V, Vijaya LB, Jasmine R. Therapeutic applications of nanorobots-respirocytes and microbivores. J Chem Pharm Res 2016; 8: 605-9.
[15]
Figueiredo A, Silva O, Cabrita S. Inflammatory reaction post implantation of bone graft materials. Exp Pathol Health Sci 2012; 6(1): 15-8.
[18]
Yu X, Trase I, Ren M, Duval K, Guo X, Chen Z. Design of nanoparticle-based carriers for targeted drug delivery. J Nanomater 2016; 2016: 1-15.
[26]
Bhatia S. Nanotechnology and its drug delivery applications InNatural polymer drug delivery systems. Cham: Springer 2016; pp. 1-32.
[29]
Grigore ME. Drug delivery systems in hard tissue engineering SF J Biotechnol. Biomed Eng 2018; 1(1): 1001.
[48]
Nirwan N. Nikita, Sultana Y, Vohora D. Liposomes as multifaceted delivery system in the treatment of osteoporosis. Expert Opin Drug Deliv 2021; 18: 1-5.
[49]
Sun X, Wei J, Lyu J, et al. Bone-targeting drug delivery system of biomineral-binding liposomes loaded with icariin enhances the treatment for osteoporosis. J Nanobiotechnol 2019; 17(1): 1-6.
[53]
Lu T, Ma Y, Hu H, Chen Y, Zhao W, Chen T. Ethinylestradiol liposome preparation and its effects on ovariectomized rats’ osteoporosis. Drug Deliv 2011; 18(7): 468-77.
[54]
Salem HF, Kharshoum RM, Mahmoud M, Azim SA, Ebeid EZ. Development and characterization of a novel nano-liposomal formulation of alendronate sodium loaded with biodegradable polymer. Ars Pharm 2018; 59(1): 9-20.
[60]
Méndez NA, Barreda CT, Vega AF, et al. Design and development of pharmaceutical microprocesses in the production of nanomedicine. Nanostructures for Oral Medicine. Elsevier 2017; pp. 669-97.
[65]
Sree NV, Udayasri P, Suresh V, Rao KS. Osteoporosis: Use of nanoparticles for the treatment of osteoporosis. Biomed Pharmacol J 2015; 2(2): 477-88.
[73]
Bhaskaran S. Formulation of natural polymeric nanoparticles to overcome barriers for the treatment of osteoporosis. J Adv Med Pharm Sci 2017; 12(3): 1-7.
[90]
Rathod HJ, Mehta DP. A review on pharmaceutical gel. Int J Pharm Sci Res 2015; 1(1): 33-47.
[94]
Amani N, Javar HA, Dorkoosh FA, et al. Preparation and pulsatile release evaluation of teriparatide-loaded multilayer implant composed of polyanhydride-hydrogel layers using spin coating for the treatment of osteoporosis. J Pharm Innov 2020; 16: 1-22.
[97]
García MC, Uberman PM. Nanohybrid Filler-Based Drug-Delivery System. Nanocarriers for Drug Delivery. Elsevier 2019; pp. 43-79.
[100]
Pundir S, Badola A, Sharma D. Sustained release matrix technology and recent advance in matrix drug delivery system: A review. Int J Drug Res Tech 2013; 3(1): 12-20.
[109]
Bhattarai RS, Dhandapani NV, Shrestha A. Drug delivery using alginate and chitosan beads: An overview Chron Young Sci 2011; 2(4): 192.
[112]
Moss AC. Mechanism of Action and Pharmacokinetics of Biologics. Treatment of Inflammatory Bowel Disease with Biologics. Cham: Springer 2018; pp. 1-11.
[113]
Gheita TA, Fathi HM. Biologics for osteoporosis: Where do we stand? J Musculoskelet Disord Treat 2018; 4(059): 1-4.
[115]
Quinteros DA, Bermúdez JM, Ravetti S, Cid A, Allemandi DA, Palma SD. Therapeutic use of monoclonal antibodies: General aspects and challenges for drug delivery. Nanostructures for Drug Delivery. Elsevier 2017; pp. 807-33.